160 related articles for article (PubMed ID: 16386782)
1. Persistent HPV infection after conization in patients with negative margins.
Song SH; Lee JK; Oh MJ; Hur JY; Na JY; Park YK; Saw HS
Gynecol Oncol; 2006 Jun; 101(3):418-22. PubMed ID: 16386782
[TBL] [Abstract][Full Text] [Related]
2. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
Song SH; Park HM; Eom DW; Lee JK; Lee NW; Kim AR; Hur JY; Lee KW; Park YK; Saw HS
Int J Gynecol Cancer; 2007; 17(4):858-67. PubMed ID: 17367326
[TBL] [Abstract][Full Text] [Related]
3. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
Park JY; Lee KH; Dong SM; Kang S; Park SY; Seo SS
Gynecol Oncol; 2008 Mar; 108(3):549-54. PubMed ID: 18177929
[TBL] [Abstract][Full Text] [Related]
4. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
5. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
[TBL] [Abstract][Full Text] [Related]
9. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
[TBL] [Abstract][Full Text] [Related]
10. Persistence and reappearance of high-risk human papillomavirus after conization.
Gosvig CF; Huusom LD; Andersen KK; Iftner A; Cederkvist L; Svare E; Iftner T; Kjaer SK
Gynecol Oncol; 2013 Dec; 131(3):661-6. PubMed ID: 24035849
[TBL] [Abstract][Full Text] [Related]
11. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
12. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
13. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
14. The significance of HPV in the follow-up period after treatment for CIN.
Gallwas J; Ditsch N; Hillemanns P; Friese K; Thaler C; Dannecker C
Eur J Gynaecol Oncol; 2010; 31(1):27-30. PubMed ID: 20349777
[TBL] [Abstract][Full Text] [Related]
15. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.
Kim YT; Lee JM; Hur SY; Cho CH; Kim YT; Kim SC; Kang SB
Int J Cancer; 2010 Apr; 126(8):1903-1909. PubMed ID: 19642095
[TBL] [Abstract][Full Text] [Related]
16. [Correlations of high-risk human papillomaviral load to cervical intraepithelial neoplasia grades, expression of Ki-67 and P6ink4a and follow-up].
Yi W; Wang JL; Li XH; Wei LH
Ai Zheng; 2008 May; 27(5):520-4. PubMed ID: 18479603
[TBL] [Abstract][Full Text] [Related]
17. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
18. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
[TBL] [Abstract][Full Text] [Related]
19. Negative predictive value of human papillomavirus test following conization of the cervix uteri.
Jain S; Tseng CJ; Horng SG; Soong YK; Pao CC
Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with HPV persistence after conization in patients with negative margins.
Nam K; Chung S; Kim J; Jeon S; Bae D
J Gynecol Oncol; 2009 Jun; 20(2):91-5. PubMed ID: 19590719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
